Pietras R - Search Results

1

Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy.

Pio BS, Park CK, Pietras R, Hsueh WA, Satyamurthy N, Pegram MD, Czernin J, Phelps ME, Silverman DH. Pio BS, et al. Among authors: pietras r. Mol Imaging Biol. 2006 Jan-Feb;8(1):36-42. doi: 10.1007/s11307-005-0029-9. Mol Imaging Biol. 2006. PMID: 16362149

2

Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells.

Pietras RJ, Fendly BM, Chazin VR, Pegram MD, Howell SB, Slamon DJ. Pietras RJ, et al. Oncogene. 1994 Jul;9(7):1829-38. Oncogene. 1994. PMID: 7911565

3

The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells.

Pegram MD, Finn RS, Arzoo K, Beryt M, Pietras RJ, Slamon DJ. Pegram MD, et al. Among authors: pietras rj. Oncogene. 1997 Jul 31;15(5):537-47. doi: 10.1038/sj.onc.1201222. Oncogene. 1997. PMID: 9247307

4

Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.

Pietras RJ, Pegram MD, Finn RS, Maneval DA, Slamon DJ. Pietras RJ, et al. Oncogene. 1998 Oct 29;17(17):2235-49. doi: 10.1038/sj.onc.1202132. Oncogene. 1998. PMID: 9811454

5

Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.

Pegram M, Hsu S, Lewis G, Pietras R, Beryt M, Sliwkowski M, Coombs D, Baly D, Kabbinavar F, Slamon D. Pegram M, et al. Among authors: pietras r. Oncogene. 1999 Apr 1;18(13):2241-51. doi: 10.1038/sj.onc.1202526. Oncogene. 1999. PMID: 10327070

6

Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells.

Aguilar Z, Akita RW, Finn RS, Ramos BL, Pegram MD, Kabbinavar FF, Pietras RJ, Pisacane P, Sliwkowski MX, Slamon DJ. Aguilar Z, et al. Among authors: pietras rj. Oncogene. 1999 Oct 28;18(44):6050-62. doi: 10.1038/sj.onc.1202993. Oncogene. 1999. PMID: 10557094

7

Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer.

Pegram MD, Konecny GE, O'Callaghan C, Beryt M, Pietras R, Slamon DJ. Pegram MD, et al. Among authors: pietras r. J Natl Cancer Inst. 2004 May 19;96(10):739-49. doi: 10.1093/jnci/djh131. J Natl Cancer Inst. 2004. PMID: 15150302

8

Targeted therapy: wave of the future.

Pegram MD, Pietras R, Bajamonde A, Klein P, Fyfe G. Pegram MD, et al. Among authors: pietras r. J Clin Oncol. 2005 Mar 10;23(8):1776-81. doi: 10.1200/JCO.2005.11.029. J Clin Oncol. 2005. PMID: 15755985 Review. No abstract available.

9

Thalidomide and chemotherapy combination.

Nguyen M, Tran C, Barsky S, Sun J, McBride W, Pegram M, Pietras R, Love S, Glaspy J. Nguyen M, et al. Among authors: pietras r. Int J Oncol. 1997 May;10(5):965-9. doi: 10.3892/ijo.10.5.965. Int J Oncol. 1997. PMID: 21533471

10

Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy.

Márquez-Garbán DC, Deng G, Comin-Anduix B, Garcia AJ, Xing Y, Chen HW, Cheung-Lau G, Hamilton N, Jung ME, Pietras RJ. Márquez-Garbán DC, et al. J Steroid Biochem Mol Biol. 2019 Oct;193:105415. doi: 10.1016/j.jsbmb.2019.105415. Epub 2019 Jun 19. J Steroid Biochem Mol Biol. 2019. PMID: 31226312 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters